We also observed for these patients an increase of CD8+ cells infiltrate in tumor site after neoadjuvant therapy (Fig. 4b) thus confirming that neoadjuvant chemotherapy increased CD8+ cells in liver mCRC in a paired-samples model. Here, CD8A is linked to neoplasm.